1 / 4

*p=.004; p=.005 for interaction

Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients with Baseline LDL-C <125 mg/dL. *p=.004; p=.005 for interaction. Sacks FM et al. Circulation 2002;105:1424-1428.

cana
Download Presentation

*p=.004; p=.005 for interaction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients with Baseline LDL-C <125 mg/dL *p=.004; p=.005 for interaction Sacks FM et al. Circulation 2002;105:1424-1428.

  2. Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients with Baseline LDL-C <125 mg/dL *p=.06 for RR in HDL-C groups and for interaction (HDL-C as continuous variable) †p=0.075; p=.09 for interaction Sacks FM et al. Circulation 2002;105:1424-1428.

  3. Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients with Baseline LDL-C <125 mg/dL Coronary Event Rate (%) ** * Pravastatin *p=.004 **p (interaction) =.005 Placebo >60 <60 F M + — + — + — >27 <27 <40 >40 >150 <150 Age Sex HTN Smoking DM BMI HDL-C TG Sacks FM et al. Circulation 2002;105:1424-1428.

  4. 0 1 2 3 4 5 6 7 Cumulative Coronary Event Rates in Diabetic and Nondiabetic Patients with Baseline LDL-C <125 mg/dL Placebo Diabetic Pravastatin Nondiabetic Pravastatin Diabetic Placebo Nondiabetic Cumulative Risk of Coronary Event or Procedure (%) Years Follow-up Sacks FM et al. Circulation 2002;105:1424-1428.

More Related